Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10024327 | 0.80 | HMGCR (0.30) | — | |
| Acetic Acid SCHEMBL28296552 | 0.79 | CA2 (0.38) | USP2CA2MAPK1 | |
| SCHEMBL27839877 | 0.78 | KDM4E (0.39) | CA2MAPK1 | |
| SCHEMBL329125 | 0.75 | GLB1 (0.38) | — | |
| Acetic Acid SCHEMBL29199140 | 0.75 | CA2 (0.34) | USP2CA2MAPK1 | |
| Bicarbonate SCHEMBL29180172 | 0.74 | GPR84 (0.40) | — | |
| Bicarbonate SCHEMBL28779427 | 0.73 | CA2 (0.33) | CA2MAPK1 | |
| Propionic Acid SCHEMBL27725688 | 0.73 | FFAR3 (0.36) | CA2MAPK1 | |
| Trifluoroacetic Acid SCHEMBL2761168 | 0.73 | FAAH (0.34) | CA2MAPK1 | |
| Bromide SCHEMBL23071102 | 0.73 | GLB1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9150515-B2 | Imidazolium salts and carbene metal complexes based thereon for use as bioanalytical markers for biomolecules | Ernst-Moritz-Arndt-Universität Greifswald (DE) | 2015-10-06 | — | — | US | disclosed |
| US-9150515-B2 | Imidazolium salts and carbene metal complexes based thereon for use as bioanalytical markers for biomolecules | Ernst-Moritz-Arndt-Universität Greifswald (DE) | 2015-10-06 | — | — | US | disclosed |
| EP-2616446-B1 | NEW IMIDAZOLIUM SALTS AND CARBENE METAL COMPLEXES THEREOF FOR USE AS BIOANALYTICAL MARKERS FOR BIOMOLECULES | ERNST MORITZ ARNDT UNIVERSITÄT GREIFSWALD (DE) | 2015-04-29 | — | — | EP | disclosed |
| US-20130171071-A1 | Novel Imidazolium Salts and Carbene Metal Complexes Based Thereon for Use as Bioanalytical Markers for Biomolecules | ERNST-MORITZ-ARNDT-UNIVERSITAT GREIFSWALD (DE) | 2013-07-04 | — | — | US | disclosed |
| US-20130171071-A1 | Novel Imidazolium Salts and Carbene Metal Complexes Based Thereon for Use as Bioanalytical Markers for Biomolecules | ERNST-MORITZ-ARNDT-UNIVERSITAT GREIFSWALD (DE) | 2013-07-04 | — | — | US | disclosed |
| WO-2012034880-A1 | NOVEL IMIDAZOLIUM SALTS AND CARBENE METAL COMPLEXES BASED THEREON FOR USE AS BIOANALYTICAL MARKERS FOR BIOMOLECULES | Ernst-Moritz-Arndt-Universität Greifswald (DE) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130171071-A1 | Novel Imidazolium Salts and Carbene Metal Complexes Based Thereon for Use as Bioanalytical Markers for Biomolecules | MB, COX4I1, CYC1 | HSPD1 298/4885BLM 3610/4885HSPE1 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.